492 related articles for article (PubMed ID: 23635684)
1. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
Obstet Gynecol; 2013 Apr; 121(4):829-846. PubMed ID: 23635684
[TBL] [Abstract][Full Text] [Related]
2. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S1-S27. PubMed ID: 23519301
[TBL] [Abstract][Full Text] [Related]
3. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.
Wright TC; Massad LS; Dunton CJ; Spitzer M; Wilkinson EJ; Solomon D;
J Low Genit Tract Dis; 2007 Oct; 11(4):223-39. PubMed ID: 17917567
[TBL] [Abstract][Full Text] [Related]
4. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
5. 2006 consensus guidelines for the management of women with abnormal cervical screening tests.
Wright TC; Massad LS; Dunton CJ; Spitzer M; Wilkinson EJ; Solomon D;
J Low Genit Tract Dis; 2007 Oct; 11(4):201-22. PubMed ID: 17917566
[TBL] [Abstract][Full Text] [Related]
6. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.
Wright TC; Massad LS; Dunton CJ; Spitzer M; Wilkinson EJ; Solomon D;
Am J Obstet Gynecol; 2007 Oct; 197(4):340-5. PubMed ID: 17904956
[TBL] [Abstract][Full Text] [Related]
7. Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Zhao FH; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Katki HA; Schiffman M
Ann Intern Med; 2018 Jan; 168(1):20-29. PubMed ID: 29181509
[TBL] [Abstract][Full Text] [Related]
8. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.
Wright TC; Massad LS; Dunton CJ; Spitzer M; Wilkinson EJ; Solomon D;
Am J Obstet Gynecol; 2007 Oct; 197(4):346-55. PubMed ID: 17904957
[TBL] [Abstract][Full Text] [Related]
9. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities.
Wright TC; Cox JT; Massad LS; Twiggs LB; Wilkinson EJ;
JAMA; 2002 Apr; 287(16):2120-9. PubMed ID: 11966387
[TBL] [Abstract][Full Text] [Related]
10. Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S28-35. PubMed ID: 23519302
[TBL] [Abstract][Full Text] [Related]
11. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Berkowitz RP
Obstet Gynecol; 2013 Aug; 122(2 Pt 1):393. PubMed ID: 23969811
[No Abstract] [Full Text] [Related]
12. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
13. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
14. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
[TBL] [Abstract][Full Text] [Related]
15. Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.
Demarco M; Cheung LC; Kinney WK; Wentzensen N; Lorey TS; Fetterman B; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2018 Apr; 22(2):97-103. PubMed ID: 29570564
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
17. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S78-84. PubMed ID: 23519309
[TBL] [Abstract][Full Text] [Related]
18. Management of abnormal cervical cytology screening in adolescent and young women in a canadian colposcopy centre: a descriptive analysis.
Bouchard-Fortier G; Paszat L; Murphy KJ
J Obstet Gynaecol Can; 2013 Feb; 35(2):149-55. PubMed ID: 23470065
[TBL] [Abstract][Full Text] [Related]
19. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.
Ryu KJ; Lee S; Min KJ; Kim JW; Hong JH; Song JY; Lee JK; Lee NW
Oncologist; 2015 Jun; 20(6):635-9. PubMed ID: 25964305
[TBL] [Abstract][Full Text] [Related]
20. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
